Neurocrine Biosciences Inc (NASDAQ:NBIX)

Delayed Data
As of 4:00pm ET
 -1.00 / -1.18%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 91.00, with a high estimate of 139.00 and a low estimate of 79.00. The median estimate represents a +8.55% increase from the last price of 83.83.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -357.14%
Growthannually 88.39%


Growthquarterly -32.81%
Growthannually 134.13%
Key to the earnings and sales forecast charts.